robbrierley.bsky.social
Editor-in-Chief, The Lancet Gastroenterology & Hepatology @lancetgastrohep.bsky.social. Views my own; reposting ≠ endorsement. #GastroSky #LiverSky #GISky #OncSky
👤 Joined on 22 November 2023
Followers
Following
Total Posts
@robbrierley.bsky.social🚨Our highlights from #EASLCongress 2026, featuring findings on ACLF treatment, liver transplantation care, MASLD screening, MASH therapy, and chronic HDV infection. Read more 👇 www.thelancet.com/journals/lan... @easlnews.bsky.social
Show PostCirculating tumour cells & ctDNA in patients with resectable colorectal liver #metastases: a prospective observational biomarker study Postoperative ctDNA and CTC detection are strong, independent predictors for a shorter RFS after local treatment www.thelancet.com/journals/ecl... #OncoSky #MedSky
Show PostRadiation dose escalation in locally advanced oesophageal cancer: a systematic review and meta-analysis Radiation dose escalation improves locoregional control and may enhance OS in SqCC, particularly in Asian populations www.thelancet.com/journals/ecl... #OesophagealCancer #MedSky #OncoSky
Show Post#GastroEdPick Effect of gluten and wheat on symptoms and behaviours in adults with irritable bowel syndrome: a single-centre, randomised, double-blind, sham-controlled crossover trial. @lancetgastrohep.bsky.social www.sciencedirect.com/science/arti...
Show PostOur August issue is live! Gut microbiome & nutrition, menopause & gastrointestinal health, alcohol-related liver disease, enteric nervous system & much more! www.nature.com/nrgastro/vol... #gastrosky #liversky #microsky
Show Post